New Delhi: India has an adequate buffer stock of hydroxychloroquine tablets to face any situation following the COVID 19 outbreak, said Lav Aggrawal, joint secretary in the Health Ministry on Friday.
"We have 1 crore Hydroxy-chloroquine tables for next week in possession. Additionally, we have 3.28 crore tables for this month to face any emergency situation," said Aggrawal refuting reports that India has a shortage of Hydroxy-chloroquine tablets.
India has also exported a major quantity of Hydroxy-chloroquine tables to a few counties including India's neighbouring countries and those who have been severely affected by the Covid19 pandemic.
"We have also kept in reserve 2 crore tablets for private utilisation," said Aggrawal.
Hydroxy-chloroquine is an anti-malaria drug and this is prescribed for frontline health workers in India fighting COVID-19. Till Friday, India registered 6761 positive COVID-19 cases with 6039 still active. 206 people have died and 515 people have also been cured of this infectious disease.
"We have conducted 16002 laboratory tests for COVID-19 on Thursday and 320 (2 per cent) have been found COVID positive," said Aggrawal.